Does a decision aid for prostate cancer affect different aspects of decisional regret, assessed with new regret scales? A randomized, controlled trial

Publisher： John Wiley & Sons Inc

E-ISSN： 1369-7625|19|2|459-470

ISSN： 1369-6513

Source： Health Expectations (Electronic), Vol.19, Iss.2, 2016-04, pp. : 459-470

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Decision aid use during post‐biopsy consultations for localized prostate cancer

By  

Health Expectations (Electronic), Vol. 21, Iss. 1, 2018-02 ,pp. : 279-287

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cisplatin combined with irinotecan or etoposide for untreated extensive‐stage small cell lung cancer: A multicenter randomized controlled clinical trial

By  

Thoracic Cancer, Vol. 6, Iss. 6, 2015-11 ,pp. : 785-791

John Wiley & Sons Inc

Access to resources Recommend Favorite

Circadian genes and risk of prostate cancer in the prostate cancer prevention trial

By  

Molecular Carcinogenesis, Vol. 57, Iss. 3, 2018-03 ,pp. : 462-466

John Wiley & Sons Inc

Access to resources Recommend Favorite

Psychometric assessment of the Chinese version of the decisional conflict scale in Chinese women making decision for breast cancer surgery

By  

Health Expectations (Electronic), Vol. 18, Iss. 2, 2015-04 ,pp. : 210-220

John Wiley & Sons Inc

Access to resources Recommend Favorite

The impact of DECISION+2 on patient intention to engage in shared decision making: secondary analysis of a multicentre clustered randomized trial

By  

Health Expectations (Electronic), Vol. 18, Iss. 6, 2015-12 ,pp. : 2629-2637

John Wiley & Sons Inc

Access to resources Recommend Favorite